Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • Rayno DX And Tools: Trading Pick Of The Day Trinity Biotech (TRIB)  0 comments
    Apr 28, 2014 11:08 AM | about stocks: TRIB

    Trinity Biotech (TRIB $24.90), a Buy Around $25

    Barron's published an article over the weekend recommending Trinity Biotech plc, an Irish diagnostic Company focused in point of care (POC) and clinical laboratory diagnostic tests. We agree with the article and will provide a follow-up review this week. Trinity Biotech tests are for infectious diseases, diabetes monitoring and liver and kidney diseases.

    Although the stock has a high PE of around 56, the forward PE is only 20 and the P/S is 6. The stock shows good downside support at $24. The Irish domicile offers a good opportunity for acquisitions of U.S. companies.

    Disclosure: we are long TRIB.

    Disclosure: I am long TRIB.

    Stocks: TRIB
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.